Fresenius Medical Care North America Presents New Insights Related to COVID-19 and Dialysis Innovations at Kidney Week 2020

Fresenius Medical Care North America Presents New Insights Related to COVID-19 and Dialysis Innovations at Kidney Week 2020


65 Abstracts Offered at American Society of Nephrology’s Reimagined Conference

WALTHAM, Mass. – Oct 22, 2020 – Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, today announced the presentation of 65 company-affiliated abstracts at the American Society of Nephrology (ASN) Annual Conference Kidney Week 2020 Reimagined, which runs virtually from Oct. 22-25, 2020. These publications include new insights related to COVID-19, phosphate binders, a new dialysis system under development, and new software to attain relative blood volume.

In addition to the abstracts presented online, Dr. Jeffrey Hymes, SVP of Scientific and Clinical Affairs at FMCNA and Chief Medical Officer at Fresenius Kidney Care, will discuss the company’s pandemic response during the conference’s clinical practice session “COVID-19: The Pandemic and the Outpatient Dialysis Setting” on Oct. 25 at 10:30 a.m. ET.

“The research abstracts presented this year demonstrate our approach to confronting the pandemic, along with new solutions that aim to improve the treatment of people with kidney failure,” said Dr. Robert Kossmann, Chief Medical Officer for FMCNA. “These insights showcase the breadth and depth of our research team, highlighting the many ways that we are working to advance kidney care.”

The annual symposium, reimagined virtually for 2020, is one of the most influential gatherings of kidney professionals in the world. Some of the abstracts being presented by Fresenius Medical Care, and now available online as part of ASN’s Kidney Week 2020 Reimagined, include:

 

About Fresenius Medical Care North America 
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

Insights You Might Like

 

ARTICLE

Katya Cook Fosters Professional Growth for FMCNA Emplyees

 

ARTICLE

Benifits of Replacing Your Old Central DIalysis Water System

 

ARTICLE

What Is the AquA RO System? | Dialysis Water Treatment